MELAS Clinical Trial - A Dose-escalating Clinical Trial With KH176

Status Completed

Clinical Trial Summary

Mitochondrial Diseases are rare progressive, multi-system, often early fatal disorders affecting both children and adults. KH176 is a novel chemical entity currently under development for the treatment of inherited mitochondrial diseases, including MELAS (Mitochondrial Encephalomyopathy, Lactic acidosis, and Stroke-like episodes), Leigh's Disease and Leber's Hereditary Optic Neuropathy (LHON). KH176 is a potent intracellular redox modulating agent targeting the reactive oxygen species which are important in the pathogenesis of disorders of mitochondrial oxidative phosphorylation. After demonstrating a favourable safety profile in the pre-clinical testing, the safety, tolerability and pharmacokinetic and pharmacodynamic characteristics of the compound will now be evaluated in healthy male subjects in this trial

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Leigh Disease
Leigh Syndrome
LHON
MELAS
Mitochondrial Disease
Mitochondrial Diseases
Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation

Clinical Trial Details

NCT number	NCT02544217
Study type	Interventional
Source	Khondrion BV
Contact
Status	Completed
Phase	Phase 1
Start date	May 2015
Completion date	October 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02311257` - Survey on Supplement Use in Mitochondrial Disease	N/A
Terminated	`NCT01001585` - Anesthetic Effects in Mitochondrial Disease	N/A
Completed	`NCT01642056` - EPI-743 for Metabolism or Mitochondrial Disorders	Phase 1/Phase 2
Recruiting	`NCT04419870` - Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic
Completed	`NCT00786539` - Mitochondria Inborn Errors of Metabolism and ANT Defects in Mitochondria Diseases
Active, not recruiting	`NCT02000284` - Mitochondrial Dysfunction in Autism Spectrum Disorder
Completed	`NCT04643249` - Drug-drug Interaction Study of KL1333 in Healthy Subjects	Phase 1
Completed	`NCT02154711` - Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease
Completed	`NCT01264471` - Mechanisms of Mitochondrial Defects in Gulf War Syndrome	N/A
Completed	`NCT00829270` - Economic and Medical Evaluation of the Whole Mitochondrial DNA Screening by Surveyor and Mitochips Techniques	N/A
Completed	`NCT02745938` - GDF-15 as a Biomarker for Mitochondrial Disease	N/A
Enrolling by invitation	`NCT01803906` - Tissue Sample Study for Mitochondrial Disorders
Completed	`NCT01776918` - Energy Requirements in Mitochondrial Disease	N/A
Completed	`NCT01301235` - Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy	N/A
Completed	`NCT02985710` - Assessment of Small Fiber Neuropathy in Rare Diseases Using Sudoscan	N/A
Recruiting	`NCT05241262` - Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels	Phase 1
Completed	`NCT02678637` - Calf Muscle Strength in Mitochondrial Diseases	N/A